Insiders · ZVSA

Peter Wolfe

Chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA) since December 2022

Peter Wolfe has filed 5 insider reports with the SEC since December 2022, as chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA). The latest filing, on July 15, 2025, reports grant or award at ZyVersa Therapeutics, Inc. (ZVSA).

Filings
5
Companies
1
Bought on market
None
Sold on market
None

Companies where Peter Wolfe is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
ZyVersa Therapeutics, Inc. logo
ZVSA
ZyVersa Therapeutics, Inc.
Chief Financial Officersince December 202244,585Jul 15, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Wolfe with

Other insiders at the same companies

Questions about Peter Wolfe

What is Peter Wolfe's role at ZyVersa Therapeutics, Inc.?
Peter Wolfe reports to the SEC as chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA), according to the latest filing on July 15, 2025.
How many shares does Peter Wolfe own?
After the latest filing that states it, Peter Wolfe directly owned 44,585 shares of ZyVersa Therapeutics, Inc. (ZVSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Wolfe bought or sold stock recently?
No open-market purchases or sales by Peter Wolfe are on file. The filings report grant or award.
How do I get alerts when Peter Wolfe files?
Follow Peter Wolfe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Wolfe (SEC CIK 0001954398). Totals count each trade once, skipping amendments whose original is on file, from Dec 13, 2022 on. View on SEC EDGAR